Reaktionsgleichung
[CH3:1][S:2][C:3]1[N:8]=[C:7]([C:9]2[S:13][C:12]([S:14](Cl)(=[O:16])=[O:15])=[CH:11][CH:10]=2)[CH:6]=[CH:5][N:4]=1.[NH2:18][C:19]1[CH:20]=[C:21]([C:25]2[NH:29][N:28]=[N:27][N:26]=2)[CH:22]=[CH:23][CH:24]=1>>[CH3:1][S:2][C:3]1[N:8]=[C:7]([C:9]2[S:13][C:12]([S:14]([NH:18][C:19]3[CH:24]=[CH:23][CH:22]=[C:21]([C:25]4[NH:29][N:28]=[N:27][N:26]=4)[CH:20]=3)(=[O:16])=[O:15])=[CH:11][CH:10]=2)[CH:6]=[CH:5][N:4]=1Komponenten
3
Versuchsvorschrift
The product was prepared according to General Procedure 1, described in Example 1, starting from 5-[2-(methylthio)pyrimidin-4-yl]thiophene-2-sulfonyl chloride (17 mg, 0.055 mmol) and 5-(3-aminophenyl)tetrazole (8 mg, 0.05 mmol) giving 9.3 mg (43%) of the title compound. MS (ESI+) calcd for C16H13N7O2S3 431.029285, found 431.029205.
Aufarbeitung
- customThe product was prepared
Quellen und Nachweise
- ORD-Eintrag
- ord-67db9d71143b4fb6b32630acadb2cfd4
- Quelldatensatz
- uspto-grants-2016_01
- Patentnummer
- US09233946B2
Verknüpfte Notizen
Wird geladen…